SCHEMBL2162393

SCHEMBL2162393

CC1OCc2sc(N)c(C(=O)C3CCC3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
ALDH1A1 P00352 15/20 0.36
MAPT P10636 14/20 0.36
KDM4E B2RXH2 11/20 0.36
HPGD P15428 10/20 0.36
HSD17B10 Q99714 9/20 0.36
ALOX15 P16050 7/20 0.36
GAA P10253 4/20 0.32
TSHR P16473 2/20 0.32
ALOX12 P18054 1/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
USP2 O75604 1/20 0.32
RECQL P46063 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ANO1 Q5XXA6 1/20 0.32
CASP1 P29466 2/20 0.31
CASP7 P55210 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162345 0.97 CNR1 (0.38) CNR1CNR2ALDH1A1MAPTKDM4E
SCHEMBL2162573 0.94 ALDH1A1 (0.38) CNR1CNR2ALDH1A1MAPTKDM4E
SCHEMBL2162128 0.75 CNR2 (0.44) CNR1CNR2ALDH1A1MAPTKDM4E
SCHEMBL2162281 0.74 ALDH1A1 (0.54) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL2162192 0.74 ALDH1A1 (0.50) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL2162410 0.72 CNR1 (0.46) CNR1CNR2ALDH1A1KDM4E
SCHEMBL2162435 0.70 ALDH1A1 (0.37) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL2163738 0.70 CNR2 (0.47) CNR1CNR2ADORA1
SCHEMBL2163174 0.70 CNR1 (0.37) CNR1CNR2ALDH1A1MAPTKDM4E
SCHEMBL20339216 0.69 ALOX15 (0.42) CNR1CNR2MAPTALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985768-B2 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants ABBOTT LABORATORIES (US) 2011-07-26 US disclosed
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, OPRL1 CNR1 1/4885CNR2 2/4885ALDH1A1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.